http://www.legislation.gov.uk/ukdsi/m/data.feed 2024-10-21T23:59:59Z 20 1 1 6 116 http://www.legislation.gov.uk/id/ukdsi/2024/9780348256161 2024-01-10T15:41:18Z 2024-01-10T15:36:13.797788Z

These Regulations amend the Human Medicines Regulations 2012 (“the 2012 Regulations”), which govern the arrangements across the United Kingdom for the licensing, manufacture, wholesale dealing and sale or supply of medicines for human use. These Regulations extend to England and Wales and Scotland only.

http://www.legislation.gov.uk/id/ukdsi/2024/9780348258523 2024-04-30T02:05:16Z 2024-03-05T03:01:11.449419Z The Veterinary Medicines (Amendment etc.) Regulations 2024

These Regulations amend the Veterinary Medicines Regulations 2013 (S.I. 2013/2033, “the 2013 Regulations”) in respect of Great Britain only.

http://www.legislation.gov.uk/id/ukdsi/2024/9780348260908 2024-05-21T02:02:07Z 2024-04-29T10:04:42.12226Z

These Regulations amend the Human Medicines Regulations 2012 (S.I. 2012/1916) (“HMRs”) which govern the arrangements across the United Kingdom for the licensing, manufacture, wholesale dealing and sale or supply of medicines for human use. The amendments extend to the whole of the United Kingdom.

http://www.legislation.gov.uk/id/ukdsi/2024/9780348261387 2024-05-13T14:09:42Z 2024-05-13T14:04:34.736625Z

By virtue of section 180(1) Anti-social Behaviour, Crime and Policing Act 2014 (c. 12) (“the Act”), the Lord Chancellor may, with the consent of the Treasury, prescribe certain court fees of an amount which is intended to exceed the cost of the matter in respect of which the fee is charged. Under section 180(7) of the Act the use of that power is subject to the affirmative Parliamentary procedure.

http://www.legislation.gov.uk/id/ukdsi/2024/9780348262797 2024-09-26T08:47:24Z 2024-07-29T15:49:25.758617Z

These Regulations amend the Human Medicines Regulations 2012 (“the 2012 Regulations”), which govern the arrangements across the United Kingdom for the licensing, manufacture, wholesale dealing and sale or supply of medicines for human use.

http://www.legislation.gov.uk/id/ukdsi/2024/9780348263299 2024-09-09T10:04:48Z 2024-09-09T09:59:37.7595Z

Under section 215 of the Merchant Shipping Act 1995, general lighthouse authorities may borrow money for certain purposes and subject to obtaining the necessary consents. Under section 216(1) the aggregate amount that may be outstanding in respect of the principal of any sums borrowed is limited to £100 million. This Order increases that limit by £33 million with effect from 31 December 2024, in accordance with section 216(2) of that Act.

http://www.legislation.gov.uk/id/ukdsi/2024/9780348264579 2024-10-21T10:47:33Z 2024-10-21T10:45:32.788699Z

These Regulations amend the Human Medicines Regulations 2012 (S.I. 2012/1916) (“HMRs”) and the Medicines for Human Use (Clinical Trials) Regulations 2004 (S.I. 2004/1031) (“CTRs”). These Regulations make provision for medicinal products that are manufactured in a modular unit, to enable deployment from that site. This is known as modular manufacture (“MM”) and the products are referred to as “MM medicinal products”. The Regulations also make provision in relation to the manufacture and supply of medicines that are innovative and have particular characteristics such as a very short shelf life, or that are highly personalised to the recipient. These characteristics mean that the medicines have to be manufactured very close to the place where they are administered. The type of manufacture is known as point of care (“POC”) and the products are referred to in the Regulations as “POC medicinal products”.

http://www.legislation.gov.uk/id/ukdsi/2024/9780348264593 2024-10-21T16:19:38Z 2024-10-21T16:17:46.434576Z

These Regulations amend the Medical Devices Regulations 2002 (S.I. 2002/618) (“the 2002 Regulations”) to insert new post-market surveillance requirements. The 2002 Regulations were made under section 2(2) of the European Communities Act 1972 to implement Directives 90/385/EEC, 93/42/EEC and 98/79/EC.

http://www.legislation.gov.uk/id/ukdsi/2023/9780348244502 2023-03-31T23:10:00Z 2023-02-06T16:17:59.01887Z The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2023

These Regulations make amendments to the Medical Devices Regulations 2002 (“the 2002 Regulations”), the Blood Safety and Quality Regulations 2005 (“the 2005 Regulations”) and the Medical Devices (Northern Ireland Protocol) Regulations 2021 (“the 2021 Regulations”). They also revoke and restate the Medical Devices (Consultation Requirements) (Fees) Regulations 1995 (“the 1995 Regulations”).

http://www.legislation.gov.uk/id/ukdsi/2023/9780348245554 2023-05-30T02:04:58Z 2023-03-03T13:23:30.435315Z The Merchant Shipping (Fire Protection) Regulations 2023

These Regulations implement amendments to Chapter II-2 of the International Convention for the Safety of Life at Sea, 1974 (“the Convention”) relating to fire protection, fire detection and fire extinction, and also make provision in respect of ships to which the Convention does not apply. The Regulations revoke and replace the Merchant Shipping (Fire Protection: Large Ships) Regulations 1998 (S.I. 1998/1012), the Merchant Shipping (Fire Protection) Regulations 2003 (S.I. 2003/2950) and the provisions that amend both sets of Regulations.

http://www.legislation.gov.uk/id/ukdsi/2023/9780348247657 2023-06-30T23:10:00Z 2023-04-27T13:07:11.062247Z The Medical Devices (Amendment) (Great Britain) Regulations 2023

These Regulations amend the Medical Devices Regulations 2002 (S.I 2002/618) (“the 2002 Regulations”) to extend the periods for which certain medical devices that comply with EU legislation can be placed on the market in Great Britain. The 2002 Regulations were made under section 2(2) of the European Communities Act 1972, the Consumer Protection Act 1987 and the Finance Act 1973, and implemented Directive 90/385/EEC, Directive 93/42/EEC and Directive 98/79/EC.

http://www.legislation.gov.uk/id/ukdsi/2023/9780348249446 2023-09-20T02:10:53Z 2023-06-29T14:34:53.21353Z The Human Medicines (Amendment Relating to Original Pack Dispensing) (England and Wales and Scotland) Regulations 2023

These Regulations amend the Human Medicines Regulations 2012 (S.I. 2012/1916) (“HMRs”) which govern the arrangements across the United Kingdom for the licensing, manufacture, wholesale dealing and sale or supply of medicines for human use. The amendments extend to England and Wales and Scotland only and create new dispensing provisions for prescription only medicines. Regulation 214(1) of the HMRs requires prescription only medicines to be sold or supplied in accordance with a prescription given by an appropriate practitioner, subject to exceptions contained in Chapter 3 (exemptions) of Part 12 (Dealings with medicinal products).

http://www.legislation.gov.uk/id/ukdsi/2023/9780348250114 2023-10-25T10:06:28Z 2023-07-17T14:37:21.176368Z The Courts (Prescribed Recordings) Order 2023

This Order prescribes the conditions to be satisfied for section 41 of the Criminal Justice Act 1925 (which makes it an offence to film in court) and section 9 of the Contempt of Court Act 1981 (which provides that it is a contempt of court to record sound in court except with the permission of the court) not to apply to recordings undertaken by CCTV or bodyworn cameras, or to certain photographs taken to mark the making of an adoption order. Section 41 and section 9 are referred to below as “the statutory prohibitions”.

http://www.legislation.gov.uk/id/ukdsi/2023/9780348253696 2024-02-28T16:04:13Z 2023-11-14T17:34:55.503588Z The Medical Devices (In Vitro Diagnostic Devices etc.) (Amendment) Regulations 2024

These Regulations make provision for the implementation in respect of Northern Ireland of Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (“Regulation (EU) 2017/746”). Article 5(4) of the Windsor Framework between the United Kingdom and the European Union (“the Windsor Framework”) provides that the EU law listed in Annex 2 to the Windsor Framework will apply to and in the UK, in respect of Northern Ireland. Regulation (EU) 2017/746 is listed in Annex 2 and applied from 26 May 2022. Section 7A of the European Union (Withdrawal) Act 2018 gives effect to Regulation (EU) 2017/746 in domestic law.

http://www.legislation.gov.uk/id/ukdsi/2022/9780348228748 2023-04-24T09:13:45Z 2021-11-04T13:02:00.002324Z The Merchant Shipping (Control and Management of Ships’ Ballast Water and Sediments) Order 2022

This Order enables regulations to be made to give effect to the International Convention for the Control and Management of Ships’ Ballast Water and Sediments, 2004.

http://www.legislation.gov.uk/id/ukdsi/2022/9780348231861 2023-04-24T09:13:45Z 2022-02-07T16:44:38.433514Z The Commissioner for Patient Safety (Appointment and Operation) (England) Regulations 2022

These Regulations make provision about the appointment and operation of the Commissioner for Patient Safety (the “Commissioner”) established under the Medicines and Medical Devices Act 2021 (c. 3).

http://www.legislation.gov.uk/id/ukdsi/2022/9780348231885 2023-04-24T09:13:45Z 2022-02-07T16:57:40.94554Z The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2022

These Regulations amend the Human Medicines Regulations 2012 (“the 2012 Regulations”), which govern the arrangements, across the United Kingdom, for the licensing, manufacture, wholesale dealing and sale or supply of human medicines for human use. The provisions in the 2012 Regulations to which the Note refers are presently due to cease to have effect on 1st April 2022.

http://www.legislation.gov.uk/id/ukdsi/2022/9780348231892 2023-04-24T09:13:45Z 2022-02-07T17:22:51.690754Z The Human Medicines (Amendments Relating to the Early Access to Medicines Scheme) Regulations 2022

These Regulations amend the Human Medicines Regulations 2012 (“the 2012 Regulations”), which govern the arrangements across the United Kingdom for the licensing, manufacture, wholesale dealing and sale or supply of medicines for human use, and the Medicines for Human Use (Clinical Trials) Regulations 2004 (“the 2004 Regulations”), which govern the conduct of clinical trials of medicinal products for human use. The amendments make provision for the establishment and operation of the statutory version of the Early Access to Medicine Scheme (EAMS) – there has previously been a non-statutory version of the Scheme. The EAMS has the purpose of giving patients with life threatening or seriously debilitating conditions access to medicinal products that are either not authorised or not authorised for that use.

http://www.legislation.gov.uk/id/ukdsi/2022/9780348234664 2023-04-24T09:13:45Z 2022-04-28T09:43:50.830509Z The Pharmacy (Responsible Pharmacists, Superintendent Pharmacists etc.) Order 2022

This Order principally makes provision relating to the position and responsibilities of a superintendent of a body corporate that is carrying on a retail pharmacy business, and in relation to the responsibilities of the responsible pharmacist who is in day to day charge of particular retail pharmacy premises.

http://www.legislation.gov.uk/id/ukdsi/2022/9780348234671 2023-04-24T09:13:45Z 2022-04-28T09:33:26.312016Z The Pharmacy (Preparation and Dispensing Errors – Hospital and Other Pharmacy Services) Order 2022

This Order makes provision relating to preparation errors and dispensing errors by registered pharmacists and registered pharmacy technicians, or persons supervised by them, in the course of the provision of certain pharmacy services. Pharmacy technicians are not statutorily registered in Northern Ireland, and so, as regards Northern Ireland, this Order only makes provision relating to preparation errors and dispensing errors by registered pharmacists and persons supervised by them.